Investigational Drug Information for Prinomastat
✉ Email this page to a colleague
What is the drug development status for Prinomastat?
Prinomastat is an investigational drug.
There have been 3 clinical trials for Prinomastat.
The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 1998.
The most common disease conditions in clinical trials are Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, and Nervous System Neoplasms. The leading clinical trial sponsors are Pfizer and [disabled in preview].
Summary for Prinomastat
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 3,812 |
WIPO Patent Applications | 1,520 |
Japanese Patent Applications | 140 |
Clinical Trial Progress | Phase 3 (1998-03-01) |
Vendors | 0 |
Recent Clinical Trials for Prinomastat
Title | Sponsor | Phase |
---|---|---|
Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | Pfizer | Phase 2 |
Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung Cancer | Pfizer | Phase 3 |
Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer | Pfizer | Phase 3 |
Clinical Trial Summary for Prinomastat
Top disease conditions for Prinomastat
Top clinical trial sponsors for Prinomastat
US Patents for Prinomastat
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |